Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Briciclib alaninate vs placebo in advanced hepatocellular carcinoma
CTR20180831Phase 3Suspended
- Sponsor
- Zai Lab
- Start
- Jun 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of briciclib alaninate in hepatocellular carcinoma (HCC), sponsored by Zai Lab. Started Jun 2018; status: suspended.
02
Drugs
briciclib alaninate
03
Conditions
hepatocellular carcinoma (HCC)
Beyond the preview
Go deeper on CTR20180831.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20180831.